You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Therapy Areas: Cardiovascular
Nuwellis completes Rendiatech acquisition
Login
Username:

Password:


Related Headlines

Celyad Oncology sells C-Cathez catheter to CellProthera

Realheart secures European patent for artificial heart technology

Cumberland Pharmaceuticals secures FDA Fast Track status for DMD heart‑disease therapy ifetroban

Boehringer Ingelheim's VETMEDIN gains US FDA approval to delay congestive heart failure onset in dogs

Myqorzo and Redemplo receive regulatory approval in China

Cereno Scientific publishes first peer-reviewed data on CS014, highlighting antithrombotic efficacy without bleeding risk

Kestra partners with Biobeat to add cuffless blood pressure monitoring to wearable defibrillator

Organon signs commercialisation agreement for Nilemdo across six European markets

Antin to acquire clinical trial equipment provider Emsere

GSK wins European Commission approval for Shingrix prefilled syringe

Tri-City Cardiology adds new members to care team

Italfarmaco and JCR PHarmaceuticals strike Japan deal for givinostat and expand rare disease collaboration

GENinCode expands Mexico presence with CARDIO inCode-Score distribution agreement

Cereno Scientific's Phase IIb trial of CS1 in PAH approved by US FDA

InsiteOne agrees strategic partnerships with ASCEND Cardiovascular and Apollo Enterprise Imaging

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026